Surge in Open Interest for Mankind Pharma Signals Increased Trading Activity and Market Dynamics
Mankind Pharma Ltd has seen a significant rise in open interest, reaching 14,986 contracts, alongside a trading volume of 29,761 contracts. The stock has outperformed its sector slightly, hitting an intraday high of Rs 2,561, although investor participation has declined with a notable drop in delivery volume.
Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 14,986 contracts, marking a notable rise of 3,809 contracts or 34.08% from the previous open interest of 11,177 contracts. This surge coincides with a trading volume of 29,761 contracts, reflecting robust activity in the derivatives market.In terms of price performance, Mankind Pharma's stock has outperformed its sector by 0.47%, reaching an intraday high of Rs 2,561, which represents a 3.85% increase for the day. The stock is currently positioned above its 50-day and 100-day moving averages, although it remains below its 5-day, 20-day, and 200-day moving averages.
Despite this positive price movement, there has been a decline in investor participation, with delivery volume dropping by 41.61% compared to the 5-day average. The liquidity remains adequate, supporting a trade size of Rs 2.87 crore based on 2% of the 5-day average traded value.
Overall, the notable increase in open interest for Mankind Pharma highlights a shift in market dynamics, reflecting heightened trading activity without indicating future price movements.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
